<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04124471</url>
  </required_header>
  <id_info>
    <org_study_id>19-016222</org_study_id>
    <secondary_id>R61HL151253-01</secondary_id>
    <nct_id>NCT04124471</nct_id>
  </id_info>
  <brief_title>Investigating the Experience of Living With Down Syndrome and Obstructive Sleep Apnea Syndrome (Stage 1)</brief_title>
  <official_title>Positive Airway Pressure for the Treatment of the Obstructive Sleep Apnea Syndrome in Children With Down Syndrome (Stage 1)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to identify the perceptions, beliefs, and
      family-relevant outcomes regarding the treatment of OSAS with PAP in children with DS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center outpatient study to be performed at two clinical sites: Children's
      Hospital of Philadelphia and Cincinnati Children's Hospital. Forty Caregivers of children
      with DS and OSAS treated with PAP and their children will be enrolled. The study comprises
      one 30-minute open-ended semi-structured interview per caregiver. The duration of the
      interview is approximate. It will last up to 30 minutes as some families may want to include
      more details.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2, 2019</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PAP Acceptability</measure>
    <time_frame>one day</time_frame>
    <description>Perform qualitative interviews to determine factors that impact PAP acceptability and use in youth with DS and OSAS, and identify family-centered outcomes to inform the development of an intervention to improve adherence to CPAP</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Down Syndrome</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Open-ended semi-structured interviews</intervention_name>
    <description>Semi-structured interviews will explore such key constructs as knowledge/belief about OSAS and PAP therapy, routines and resources that promote or limit PAP use, barriers, self-efficacy, and communication and attitudes about PAP. The interviews will be performed with the parent and that they will be audio-recorded.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria -- Patients

          -  Children with DS and OSAS treated with PAP for at least 6 months

          -  Children aged between 6 and 17.5 years

          -  English proficiency

        Inclusion Criteria -- Caregivers

          -  Parent or legal guardian of an eligible patient subject

          -  English proficiency

          -  Must live with the patient subject at least 4 nights of the week

        Exclusion Criteria -- Patients

          -  In foster care

          -  Diagnosed with major illness, such as leukemia or severe cyanotic congenital heart
             disease listed for cardiac transplant as these severe diseases may add confounders

        Exclusion Criteria -- Caregivers

          -  Foster parent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ignacio E Tapia, MD</last_name>
    <phone>(267) 426-5842</phone>
    <email>tapia@email.chop.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruth Bradford</last_name>
    <phone>(267) 246-5747</phone>
    <email>bradford@email.chop.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio E Tapia, MD</last_name>
      <phone>267-426-5842</phone>
      <email>tapia@email.chop.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mary Pipan, MD</last_name>
      <phone>(267) 426-5200</phone>
      <email>pipan@email.chop.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 4, 2019</study_first_submitted>
  <study_first_submitted_qc>October 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2019</study_first_posted>
  <last_update_submitted>October 14, 2019</last_update_submitted>
  <last_update_submitted_qc>October 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Down Syndrome</keyword>
  <keyword>Obstructive Sleep Apnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

